A new prospective study in the European Journal of Internal Medicine offers some evidence that the use of cannabis in older patients (mean age 70.42 years) with hypertension was associated with a reduction in blood pressure in those patients. The study sample size was small (26 patients), but the results suggested that 24-hour ambulatory mean systolic blood pressure was reduced by 5 mm Hg and diastolic by 4.5 mm Hg. “This study is part of our ongoing effort to provide clinical research on the actual physiological effects of cannabis over time,” one authors said.
DocWire News conducted two video interviews this past month with two difference specialists in vascular medicine. Elliott Haut, MD, of the Johns Hopkins School of Medicine, talked about why it’s a great time to be a practitioner treating patients with venous thromboembolism (VTE), as well as the impact of the pandemic on his practice and thinking. Kelley Branch, MD, of Washington University, provided some timely updates on what’s going on in the world of atherosclerotic disease (including coronary artery disease and peripheral artery disease), and also discussed the impact that COVID-19 has had on his practice and patients. Both videos are worth your time.
Finally, a recent study in Stroke suggested that drinking green tea and coffee was linked with a reduced mortality risk in patients who had survived a heart attack or a stroke. The 46,000-plus patient population taken from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) study. The degree of the observed benefit corresponded with quantity of green tea consumed (with the greatest benefit coming with seven cups or more per day). In patients with no history of myocardial infarction or stroke, coffee consumption was inversely associated with the risk for all-cause mortality.